Financial News
Atai Life Sciences N.V. (NQ: ATAI )
1.535
-0.055
(-3.46%)
Streaming Delayed Price
Updated: 1:44 PM EST, Nov 21, 2024
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 894,468 |
| Open | 1.590 |
| Bid (Size) | 1.530 (60) |
| Ask (Size) | 1.540 (33) |
| Prev. Close | 1.590 |
| Today's Range | 1.510 - 1.600 |
| 52wk Range | 1.025 - 2.850 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Atai Q3 Report: Strong Cash Position, Clinical Pipeline Growth
November 13, 2024
Psychedelics 2.0: Companies Explore Safer, More Targeted Therapies
October 04, 2024
Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week
September 15, 2024
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th
September 10, 2024
ATAI Stock Earnings: ATAI Life Sciences Misses EPS for Q2 2024
August 13, 2024
3 Dirt-Cheap Drug Developers With Blockbuster Potential
July 11, 2024
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers
July 08, 2024
3 Psychedelic Stocks to Ride to the Moon and Beyond
July 06, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
